Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Cesca Therapeutics, Inc. (KOOL) Starts Presentation at 2015 Marcum MicroCap Conference

Posted on May 28, 2015 by MissionIR

Cesca Therapeutics aims its resources at research, development and marketing of autologous cell-based therapeutics for use in regenerative medicine. KOOL develops and manufactures automated blood and bone marrow processing systems that assist in the separation, processing and preservation of cell and tissue therapy products. Products include but are not limited to SurgWerks platform, a proprietary stem cell therapy.  For more information, visit the company website at www.cescatherapeutics.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.